World Health Energy Holdings, Inc. (WHEN) Research & Development (2019 - 2023)

World Health Energy Holdings has reported Research & Development for 5 years, with the latest figure at $427965.0 in Q3 2023.

• For the quarter ending Q3 2023, Research & Development fell 18.98% year-over-year to $427965.0; the trailing twelve-month figure through Sep 2023 stood at $1.8 million (up 67.32% YoY), and the FY2022 full-year result was $1.4 million, up 179.72% from the prior year.
• Research & Development for Q3 2023 stood at $427965.0, down from $502187.0 in the prior quarter.
• The five-year high for Research & Development was $528211.0 in Q3 2022, with the low at $47406.0 in Q2 2020.
• Historically, Research & Development has averaged $223831.9 across 5 years, with a median of $142093.5 in 2020.
• Annual changes were most pronounced in 2021 — Research & Development sank 33.38% — and 2022, when it surged 337.62%.
• World Health Energy Holdings' Research & Development stood at $89263.0 in 2019, then surged by 80.01% to $160681.0 in 2020, then slipped by 23.72% to $122560.0 in 2021, then surged by 235.34% to $410990.0 in 2022, then grew by 4.13% to $427965.0 in 2023.
• The last three Research & Development figures came in at $427965.0 (Q3 2023), $502187.0 (Q2 2023), and $502935.0 (Q1 2023), per Business Quant data.